Otonomy Announces Multiple Presentations for Hearing Loss and Tinnitus Programs at Upcoming Association for Research in Otolaryngology Meeting

Back to Jobs

Data Support Potential of OTO-413 as a Treatment for Synaptopathy-Related Hearing Loss SAN DIEGO , Feb. 06, 2018 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ:OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced seven data

Apply Now